New Nordic Healthbrands AB (publ)
Symbol: NNH.ST
STO
19.6
SEKMarktpreis heute
-12.6719
P/E-Verhältnis
0.0178
PEG-Verhältnis
121.43M
MRK Kapital
- 0.00%
DIV Rendite
New Nordic Healthbrands AB (publ) (NNH-ST) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 53.85 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 433.07 | 101.9 | 116.5 | 97 | ||||||||||||||||
balance-sheet.row.inventory | 408.14 | 105.1 | 110.2 | 116.5 | ||||||||||||||||
balance-sheet.row.other-current-assets | 54.39 | 9.1 | 0 | 2.8 | ||||||||||||||||
balance-sheet.row.total-current-assets | 949.46 | 230 | 237.3 | 228.2 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 16.37 | 4.4 | 3.2 | 2.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 11.6 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 11.6 | 0.5 | 3.6 | 3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0.92 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.tax-assets | 10.23 | 10.2 | 7 | 4.2 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 33.43 | 3.1 | -7 | 0 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 72.55 | 19.1 | 14.3 | 10.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1022 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.account-payables | 324.31 | 86.4 | 66.5 | 66 | ||||||||||||||||
balance-sheet.row.short-term-debt | 135.72 | 26.6 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.tax-payables | 10.27 | 2 | 1.7 | 3.6 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 8.22 | 2.2 | 1.6 | 0 | ||||||||||||||||
Deferred Revenue Non Current | -0.27 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.94 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 66.61 | 25.3 | 22.6 | 7.6 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 9.16 | 2.8 | 1.6 | 3.4 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-liab | 583.3 | 143 | 139.1 | 118 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 24.78 | 6.2 | 6.2 | 6.2 | ||||||||||||||||
balance-sheet.row.retained-earnings | 300.07 | 96.8 | 106.4 | 114.1 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 413.92 | 99.8 | 106.4 | 0.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -300.07 | -96.8 | -106.4 | -0.5 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 438.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1022 | 249.1 | 251.7 | 238.4 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 438.7 | 106 | 112.6 | 120.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1022 | - | - | - | ||||||||||||||||
Total Investments | 9.57 | 0.9 | 7.5 | 0.6 | ||||||||||||||||
balance-sheet.row.total-debt | 143.94 | 28.8 | 48.3 | 24.4 | ||||||||||||||||
balance-sheet.row.net-debt | 90.09 | 15 | 37.6 | 12.5 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -8.61 | -6.2 | -4.7 | 28.5 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2.03 | 1.2 | 1.6 | 0.9 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 14.87 | 31.7 | -3.4 | -31.1 | ||||||||||||||||
cash-flows.row.account-receivables | -3.85 | 2.8 | -10.4 | -4.6 | ||||||||||||||||
cash-flows.row.inventory | -12.04 | 4.9 | 6.3 | -35.8 | ||||||||||||||||
cash-flows.row.account-payables | 30.77 | 24 | 0.8 | 9.3 | ||||||||||||||||
cash-flows.row.other-working-capital | 0.66 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -1.29 | 1.3 | -9 | -6.2 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 5.48 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -3.16 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0.11 | -0.3 | 0 | -0.3 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -3.05 | -3.4 | -2.6 | -3 | ||||||||||||||||
cash-flows.row.debt-repayment | -28.42 | -21.2 | -24.3 | -22.9 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -7.7 | -9.3 | ||||||||||||||||
cash-flows.row.other-financing-activites | -7.01 | 0 | 48.7 | 44.2 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -3.96 | -21.2 | 16.6 | 12.1 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.14 | -0.3 | 0.3 | 0.3 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -1.68 | 3.1 | -1.2 | 1.5 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 53.85 | 13.8 | 10.7 | 11.9 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 55.53 | 10.7 | 11.9 | 10.4 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 5.48 | 28 | -15.5 | -7.9 | ||||||||||||||||
cash-flows.row.capital-expenditure | -3.16 | -3.1 | -3 | -2.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 2.31 | 25 | -18.4 | -10.6 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 537.81 | 533.8 | 487.5 | 514.8 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 370.92 | 536.3 | 169 | 164.8 | ||||||||||||||||
income-statement-row.row.gross-profit | 166.89 | -2.5 | 318.5 | 350 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0.67 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 139.45 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 360.46 | 0.7 | 323.2 | 321.5 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 546.99 | 537 | 492.3 | 486.3 | ||||||||||||||||
income-statement-row.row.interest-income | 0.72 | 0.1 | 0 | 0 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.61 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -2.07 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 323.2 | 56.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -2.07 | -2.8 | -0.4 | -0.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 2.61 | 2.8 | 1.5 | 0.6 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 2.03 | 1.2 | 2.8 | 0.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -7.15 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -9.19 | -3.2 | -4.7 | 28.5 | ||||||||||||||||
income-statement-row.row.income-before-tax | -11.26 | -5.9 | -5.2 | 28 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -1.09 | 0.3 | -2.3 | 6.7 | ||||||||||||||||
income-statement-row.row.net-income | -10.17 | -6.2 | -2.8 | 21.3 |
Häufig gestellte Frage
Wie hoch ist die New Nordic Healthbrands AB (publ) (NNH.ST) Gesamtvermögen?
New Nordic Healthbrands AB (publ) (NNH.ST) Gesamtvermögen ist 249060000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 272769000.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.310.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 0.373.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -0.019.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -0.017.
Was ist der New Nordic Healthbrands AB (publ) (NNH.ST) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -6194000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 28824000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 672000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 9865000.000.